Trulieve Cannabis (TRLV) versus The Competition Head to Head Contrast

Trulieve Cannabis (NYSE:TRLV) is one of 898 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its competitors? We will compare Trulieve Cannabis to similar companies based on the strength of its risk, analyst recommendations, dividends, earnings, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Trulieve Cannabis and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trulieve Cannabis	1	1	1	0	2.00
Trulieve Cannabis Competitors	7746	13793	25597	1021	2.41

Trulieve Cannabis currently has a consensus price target of $15.00, indicating a potential upside of 49.78%. As a group, “Pharmaceuticals” companies have a potential upside of 34.86%. Given Trulieve Cannabis’ higher possible upside, equities analysts clearly believe Trulieve Cannabis is more favorable than its competitors.

Institutional & Insider Ownership

32.4% of shares of all “Pharmaceuticals” companies are owned by institutional investors. 3.8% of Trulieve Cannabis shares are owned by company insiders. Comparatively, 14.1% of shares of all “Pharmaceuticals” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Trulieve Cannabis and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Trulieve Cannabis	$1.18 billion	-$116.38 million	91.05
Trulieve Cannabis Competitors	$3.54 billion	$3.17 billion	548.13

Trulieve Cannabis’ competitors have higher revenue and earnings than Trulieve Cannabis. Trulieve Cannabis is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Trulieve Cannabis and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Trulieve Cannabis	-41.55%	-4.24%	-1.72%
Trulieve Cannabis Competitors	-2,378.15%	-221.75%	-16.00%

Summary

Trulieve Cannabis competitors beat Trulieve Cannabis on 8 of the 12 factors compared.

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.